These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5066323)

  • 41. Inhalation performance of pollen-shape carrier in dry powder formulation with different drug mixing ratios: comparison with lactose carrier.
    Hassan MS; Lau R
    Int J Pharm; 2010 Feb; 386(1-2):6-14. PubMed ID: 19922775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Application of powder failure testing equipment in assessing effect on glidants on flowability of cohesive pharmaceutical powders.
    York P
    J Pharm Sci; 1975 Jul; 64(7):1216-21. PubMed ID: 1151687
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of factors affecting the encapsulation of powders in hard gelatin capsules. I. Semi-automatic capsule machines.
    Reier G; Cohn R; Rock S; Wagenblast F
    J Pharm Sci; 1968 Apr; 57(4):660-6. PubMed ID: 5652161
    [No Abstract]   [Full Text] [Related]  

  • 44. A comparison of the pore structure of tablets prepared from force screened and comminuted granules.
    Selkirk AB
    J Pharm Pharmacol; 1973 Mar; 25(3):258-9. PubMed ID: 4146328
    [No Abstract]   [Full Text] [Related]  

  • 45. Influence of raw material properties upon critical quality attributes of continuously produced granules and tablets.
    Fonteyne M; Wickström H; Peeters E; Vercruysse J; Ehlers H; Peters BH; Remon JP; Vervaet C; Ketolainen J; Sandler N; Rantanen J; Naelapää K; De Beer T
    Eur J Pharm Biopharm; 2014 Jul; 87(2):252-63. PubMed ID: 24589422
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Blending of agglomerates into powders 1: Quantification of abrasion rate.
    Willemsz TA; Oostra W; Hooijmaijers R; de Vegt O; Morad N; Vromans H; Frijlink HW; Van der Voort Maarschalk K
    Int J Pharm; 2010 Mar; 387(1-2):87-92. PubMed ID: 20015470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Irradiation field in works with tin 113-indium 113m-column and indium 113m].
    Grebe SF; Römer M; Lichy D; Dietzel F
    Strahlentherapie; 1970 Oct; 140(4):448-51. PubMed ID: 5510463
    [No Abstract]   [Full Text] [Related]  

  • 48. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
    Kaialy W; Ticehurst M; Nokhodchi A
    Int J Pharm; 2012 Feb; 423(2):184-94. PubMed ID: 22197772
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Roller compaction: Effect of relative humidity of lactose powder.
    Omar CS; Dhenge RM; Palzer S; Hounslow MJ; Salman AD
    Eur J Pharm Biopharm; 2016 Sep; 106():26-37. PubMed ID: 26940133
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Preparation of budesonide sustained-release dry powder for inhalation and influence of lactose content].
    Liang ZL; Wang XH; Ni R; Zhang L; Muenster U; Mao SR
    Yao Xue Xue Bao; 2015 Sep; 50(9):1180-5. PubMed ID: 26757557
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An investigation of the pore structure of tablets of sucrose and lactose by mercury porosimetry.
    Selkirk AB; Ganderton D
    J Pharm Pharmacol; 1970 Dec; ():Suppl:79S+. PubMed ID: 4395587
    [No Abstract]   [Full Text] [Related]  

  • 52. Drug/lactose co-micronization by jet milling to improve aerosolization properties of a powder for inhalation.
    Giry K; Péan JM; Giraud L; Marsas S; Rolland H; Wüthrich P
    Int J Pharm; 2006 Sep; 321(1-2):162-6. PubMed ID: 16797150
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Technology of effervescent granules. Physico-chemical study].
    Joachim J; Kalantzis G; Jacob M; Mention J; Maury L; Rambaud J
    J Pharm Belg; 1986; 41(4):197-208. PubMed ID: 3783403
    [No Abstract]   [Full Text] [Related]  

  • 54. Studies on granulation in a small planetary mixer. II. Granulation of lactose and an antacid mixture.
    Lindberg NO
    Acta Pharm Suec; 1977; 14(2):197-204. PubMed ID: 906837
    [No Abstract]   [Full Text] [Related]  

  • 55. Elastic modulus measurements from individual lactose particles using atomic force microscopy.
    Perkins M; Ebbens SJ; Hayes S; Roberts CJ; Madden CE; Luk SY; Patel N
    Int J Pharm; 2007 Mar; 332(1-2):168-75. PubMed ID: 17074456
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Albumin suspensions labelled with generator radionuclides. II. Labelling of reserve albumin suspensions with technetium-99m and indium-113m].
    Komárek P; Chalabala M; Vavrejn B
    Cesk Farm; 1980 May; 29(3-4):81-5. PubMed ID: 7407951
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of temperature on the tensile strength of pharmaceutical powders.
    Britten JR; Pilpel N
    J Pharm Pharmacol; 1978 Nov; 30(11):673-7. PubMed ID: 31427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of inhalable dry powder formulation of basic fibroblast growth factor.
    Ibrahim BM; Jun SW; Lee MY; Kang SH; Yeo Y
    Int J Pharm; 2010 Jan; 385(1-2):66-72. PubMed ID: 19853028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insensitivity of compaction properties of brittle granules to size enlargement by roller compaction.
    Wu SJ; Sun C
    J Pharm Sci; 2007 May; 96(5):1445-50. PubMed ID: 17455348
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calibration sampling paradox in near infrared spectroscopy: a case study of multi-component powder blend.
    Karande AD; Liew CV; Heng PW
    Int J Pharm; 2010 Aug; 395(1-2):91-7. PubMed ID: 20472048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.